HOME
Firmenprofil
OPERATIVE ONKOLOGIE
HIPEC – Hyperthermic IntraPeritoneal Chemotherapy
ISOLIERTE ORGAN PERFUSION
PERFORMER HT
PUBLIKATIONEN
Congresses – DE
Links – DE
PRODUKTE
Performer 3
Performer HT
SERVICE
PERFUSIONSSERVICE
MULTIMEDIA
F.A.Q.
Contacts – DE
SPRACHE
English
Français
Español
Italiano
The prognosis impact of hyperthermic intraperitoneal chemotherapy (HIPEC) plus cytoreductive surgery (CRS) in advanced ovarian cancer: the meta-analysis
Guyu Zhang, Yimin Zhu, Chongdong Liu, Guangming Chao, Ran Cui and Zhenyu Zhang
Prev
Next